% | $
Quotes you view appear here for quick access.

Cleveland BioLabs, Inc. Message Board

fjmulvz 8 posts  |  Last Activity: Nov 24, 2015 7:42 PM Member since: Mar 20, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Moscow could place nuclear weapons in Syria to counter Turkey: analysts
    DEBKAfile November 24, 2015, 6:42 PM (IDT)
    Leading Russian military commentators in Moscow said Tuesday evening that Russia could place nuclear weapons in Syria if tension with Turkey continues to rise. When asked by a Western interviewer if such a situation could actually happen, one commentator said it is now considered to be a real possibility.

  • fjmulvz by fjmulvz Oct 8, 2015 8:28 AM Flag

    Our government loves to throw money at problems.

    Maybe the AP report on the black market for dirty bomb material will get their attention. C'mon USG take action!

  • Reply to

    All Things Considered

    by fpmiike Aug 25, 2015 9:58 PM
    fjmulvz fjmulvz Sep 25, 2015 7:31 PM Flag

    maybe he's a black cat

  • fjmulvz fjmulvz Sep 25, 2015 11:44 AM Flag

    I think short interest is declining today. Buy low.

  • fjmulvz fjmulvz Sep 23, 2015 9:42 AM Flag

    The reason given by BARDA, according to Venkat, was that BARDA did not agree that Cleveland's proposed studies were the proper ones to achieve FDA approval – an explanation difficult to understand in light of the FDA's ongoing communication and involvement with the company. Venkat described the letter from BARDA as "short," containing about half a page of positive statements about CBLB502, and another half-page of concerns on whether the proposed studies were the correct studies to undertake.

    "My personal feeling is that BARDA is clearly anticipating and awaiting the . . . determinations that are going to come in the meetings that we have on the second day with the FDA," Venkat said. Those meetings would eliminate any uncertainty about what studies will be acceptable for approval.

  • Reply to

    DOD award

    by gatemouth13 Sep 2, 2015 2:23 PM
    fjmulvz fjmulvz Sep 16, 2015 3:59 PM Flag

    The second DoD grant of $5m-$6M and pre EUA authorization within 4-5 months are the next couple of events that should get us back to a normal valuation...

    I think we should be around $80-$100 - Pre-split that is only $4-$5.

  • Reply to

    DOD award

    by gatemouth13 Sep 2, 2015 2:23 PM
    fjmulvz fjmulvz Sep 16, 2015 10:11 AM Flag

    One down, two to go...

  • Reply to

    DOD award

    by gatemouth13 Sep 2, 2015 2:23 PM
    fjmulvz fjmulvz Sep 5, 2015 1:45 PM Flag

    Well to keep the momentum going, and after so many setbacks, let's look optimistically at the next six months:

    1.) The second $5m - $6M funding piece by 9/30/15;
    2.) Pre-EUA status granted by December;
    3) Publication of Entolimod Phase 1 Oncology results;

    Which will hopefully set the stage for a partnership to advance Entolimod as an adjunct to one of the immune checkpoint inhibitors. I cannot determine which one of the current drug prospects would benefit most from adding a "mod" to the "mAb" but it seems like there are many candidates. So Entolimod either gives new legs to an existing drug or provides the response and efficacy that a big Pharma candidate needs to move forward.

    AstraZeneca? Merck? Roche? Cash?

4.03-0.01(-0.25%)Nov 25 3:59 PMEST